Type 2 Diabetes Trial, Not Yet Recruiting NCT07615803 Sponsor: The Children's Hospital of Zhejiang University School of Medicine Condition: Type 2 Diabetes
Printed from Voxsanity (voxsanity.com.au) — NCT07615803 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07615803
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • The patient has been diagnosed with Type 1 Diabetes (T1D) according to World Health Organization (WHO) guidelines.
  • The patient has been living with Type 1 Diabetes for 6 months or longer.
  • The patient has no difficulties with thinking, awareness, or reading ability.
  • The patient agrees to take part in the study.
  • The patient has a family member or carer who is able to understand the study materials, is mentally alert, and can answer questions freely.
  • The patient's family member or carer is willing to take part in the survey voluntarily.
  • The patient's family member or carer spends an average of at least 6 hours per day caring for the child.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • The patient has serious short-term or long-term diabetes-related complications that require urgent medical treatment and make participation difficult.
  • The patient is currently dealing with a serious health event such as an infection, recent surgery, or injury that makes it hard to participate in research.
  • The patient's family member or carer has reduced consciousness or an abnormal mental state.
  • The patient's family member or carer has a hearing or communication difficulty.
  • The patient or their family member or carer has already taken part in this survey previously.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13857128162

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
The Children's Hospital of Zhejiang University School of Medicine
Registry
ClinicalTrials.gov
Start date
1 December 2026
Est. completion
1 July 2027

Primary endpoints

Prevalence of insulin injection-related lipohypertrophy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Other trials for Type 2 Diabetes

  • NCT05345327 The George Institute · Phase 3 · Recruiting · 🇦🇺 Australian site
  • NCT06579404 University of Cambridge · Not Applicable · Recruiting · 🇦🇺 Australian site
  • NCT06908486 University of Sydney · Not Applicable · Recruiting · 🇦🇺 Australian site
  • NCT06937203 Arrowhead Pharmaceuticals · Phase 2 · Recruiting · 🇦🇺 Australian site
  • NCT06942195 University of Adelaide · Not Applicable · Recruiting · 🇦🇺 Australian site

Browse all trials for Type 2 Diabetes →

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov